Skip to content

Myriad Genetics MYGN Finite Lived Intangible Assets - Gross

Finite Lived Intangible Assets - Gross at other companies

Veracyte logo
VeracyteVCYT
$146.72M+5.2%
GeneDx Holdings logo
GeneDx HoldingsWGS
$221.5M+13.0%
Castle Biosciences logo
Castle BiosciencesCSTL
$154.06M+22.4%
Labcorp Holdings logo
Labcorp HoldingsLH
Guardant Health logo
Guardant HealthGH
Natera, Inc. logo
Natera, Inc.NTRA

Other financials

Income statement

See full
Revenue$200.4M+2.3%
Gross profit$137.6M+2.5%
Operating income-$30.7M-5.9%
Net income-$34.1M-34,000%
EPS (diluted)-$0.36

Balance sheet

See full
Cash & equivalents$126.0M+24.8%
Total debt$211.5M+34.2%
Total equity$337.4M-52.1%
Total assets$673.7M-33.0%

Cash flow

See full
Operating cash flow-$15.7M+3.7%
CapEx$18.8M+181%
Free cash flow-$19.7M+65.1%

Valuation

See full
Market cap$512.85M+13.1%
Enterprise value$598.35M+17.3%
P/S0.6×+0.1×

Profitability

See full
Gross margin70%0.0pp
Operating margin-46.9%-88.3pp
Net margin-48.2%-72.9pp
FCF margin-17%

Returns & leverage

See full
Return on equity-76.7%-98.4pp
Debt / equity0.6×+0.4×
Current ratio2.4×+0.5×

Where this comes from

Reported directly by Myriad Genetics in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsGross.

The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Myriad Genetics's finite lived intangible assets - gross.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Myriad Genetics's finite lived intangible assets - gross?
Myriad Genetics (MYGN) reported finite lived intangible assets - gross of $512M in Q1 2026.
How has Myriad Genetics's finite lived intangible assets - gross changed year-over-year?
Myriad Genetics's finite lived intangible assets - gross decreased by 14.1% year-over-year, from $595.9M to $512M.
What is the long-term trend for Myriad Genetics's finite lived intangible assets - gross?
Over 3 years (2020 to 2025), Myriad Genetics's finite lived intangible assets - gross has grown at a -14.7% compound annual growth rate (CAGR), from $825.9M to $511.9M.
What does finite lived intangible assets - gross mean?
This metric tracks the total historical cost of intangible assets that have a defined useful life, such as patents, software licenses, or customer relationships. It excludes assets with indefinite lives like certain trademarks or goodwill. It is a key indicator of the company's investment in intellectual property and intangible competitive advantages.